Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review

被引：40

作者：

Sascau, Radu ^{[1
,2
]}

Clement, Alexandra ^{[2
]}

Radu, Rodica ^{[1
,2
]}

Prisacariu, Cristina ^{[1
,2
]}

Statescu, Cristian ^{[1
,2
]}

机构：

[1] Grigore T Popa Univ Med & Pharm, Dept Internal Med, Iasi 700115, Romania

[2] Inst Cardiovasc Dis Prof Dr George M Georgescu, Dept Cardiol, Iasi 700503, Romania

来源：

NUTRIENTS | 2021年 / 13卷 / 06期

关键词：

triglyceride; triglyceride-rich lipoproteins; atherosclerosis; metabolic disorders; cardiovascular outcomes; B-CONTAINING LIPOPROTEINS; CORONARY-ARTERY-DISEASE; GLUCOSE INDEX; CHOLESTEROL RATIO; PLASMA TRIGLYCERIDES; ENDOTHELIAL-CELLS; FOLLOW-UP; APOC-III; RISK; HYPERTRIGLYCERIDEMIA;

D O I：

10.3390/nu13061774

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

While targeting elevated serum levels of low-density lipoprotein cholesterol has been the mainstay of atherosclerosis prevention and treatment for decades, the evidence regarding the atherogenic role of hypertriglyceridemia is still controversial. Various epidemiological population-based studies on statin-treated subjects nominated triglycerides, triglyceride-rich lipoproteins (namely, chylomicrons and very-low-density lipoprotein particles), and their remnants as major determinants of the substantial residual cardiovascular risk. With the triglyceride-glucose index and triglyceride to high-density lipoprotein ratio emerging as surrogate indicators of peripheral artery disease and atherosclerotic cerebrovascular disease, one can conclude that further research addressing the intricate relationship between triglycerides and atherosclerosis is warranted. Therefore, this review aims to provide insight into the current clinical and epidemiological state of knowledge on the relationship between triglycerides and atherosclerotic cardiovascular disease. It also intends to highlight the connection between triglycerides and other metabolic disorders, including diabetes mellitus, and the potential benefits of triglyceride-lowering agents on cardiovascular outcomes and all-cause mortality.

引用

页数：15

共 85 条

[71] Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100-and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes [J].

Taskinen, Marja-Riitta ;

Bjornson, Elias ;

Kahri, Juhani ;

Soderlund, Sanni ;

Matikainen, Niina ;

Porthan, Kimmo ;

Ainola, Mari ;

Hakkarainen, Antti ;

Lundbom, Nina ;

Fermanelli, Valentina ;

Fuchs, Johannes ;

Thorsell, Annika ;

Kronenberg, Florian ;

Andersson, Linda ;

Adiels, Martin ;

Packard, Chris J. ;

Boren, Jan .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (02) :962-975

[72] Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database [J].

Toth, Peter P. ;

Hull, Michael ;

Granowitz, Craig ;

Philip, Sephy .

FUTURE CARDIOLOGY, 2020, 17 (04) :743-755

[73] Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease [J].

Toth, Peter P. .

VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 :171-183

[74] Triglycerides and residual risk [J].

Vallejo-Vaz, Antonio J. ;

Corral, Pablo ;

Schreier, Laura ;

Ray, Kausik K. .

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2020, 27 (02) :95-103

[75] The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors [J].

van der Ende, M. Yldau ;

Hartman, Minke H. T. ;

Hagemeijer, Yanick ;

Meems, Laura M. G. ;

de Vries, Hendrik Sierd ;

Stolk, Ronald P. ;

de Boer, Rudolf A. ;

Sijtsma, Anna ;

van der Meer, Peter ;

Rienstra, Michiel ;

van der Harst, Pim .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 :495-500

[76] Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The REGICOR Study [J].

Velescu, A. ;

Clara, A. ;

Penafiel, J. ;

Grau, M. ;

Degano, I. R. ;

Marti, R. ;

Ramos, R. ;

Marrugat, J. ;

Elosua, R. .

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2016, 51 (05) :696-705

[77] Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study [J].

Wang, Chuan ;

Wang, Lingshu ;

Liang, Kai ;

Yan, Fei ;

Hou, Xinguo ;

Liu, Fuqiang ;

Chen, Li .

JOURNAL OF DIABETES RESEARCH, 2020, 2020

[78] Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation [J].

Wang, Limin ;

Gill, Rajan ;

Pedersen, Theresa L. ;

Higgins, Laura J. ;

Newman, John W. ;

Rutledge, John C. .

JOURNAL OF LIPID RESEARCH, 2009, 50 (02) :204-213

[79] Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome [J].

Witztum, J. L. ;

Gaudet, D. ;

Freedman, S. D. ;

Alexander, V. J. ;

Digenio, A. ;

Williams, K. R. ;

Yang, Q. ;

Hughes, S. G. ;

Geary, R. S. ;

Arca, M. ;

Stroes, E. S. G. ;

Bergeron, J. ;

Soran, H. ;

Civeira, F. ;

Hemphill, L. ;

Tsimikas, S. ;

Blom, D. J. ;

O'Dea, L. ;

Bruckert, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (06) :531-542

[80] Hypertriglyceridemia: new approaches in management and treatment [J].

Wolska, Anna ;

Yang, Zhi-Hong ;

Remaley, Alan T. .

CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (06) :331-339

← 1 2 3 4 5 6 7 8 9 →